Global Heart Failure Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Global Heart Failure Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Heart Failure Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Heart Failure Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 ACEI
1.2.3 Angiotensin II Receptor Blockers
1.2.4 ARNIs
1.2.5 Beta Blockers
1.2.6 Aldosterone Antagonists
1.2.7 Diuretics
1.3 Market by Application
1.3.1 Global Heart Failure Drugs Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Reduced Ejection Fraction
1.3.3 Preserved Ejection Fraction
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Heart Failure Drugs Market Size Estimates and Forecasts
2.1.1 Global Heart Failure Drugs Revenue 2017-2028
2.1.2 Global Heart Failure Drugs Sales 2017-2028
2.2 Heart Failure Drugs Market Size by Region: 2022 Versus 2028
2.3 Heart Failure Drugs Sales by Region (2017-2028)
2.3.1 Global Heart Failure Drugs Sales by Region: 2017-2022
2.3.2 Global Heart Failure Drugs Sales Forecast by Region (2023-2028)
2.3.3 Global Heart Failure Drugs Sales Market Share by Region (2017-2028)
2.4 Heart Failure Drugs Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Heart Failure Drugs Revenue by Region: 2017-2022
2.4.2 Global Heart Failure Drugs Revenue Forecast by Region (2023-2028)
2.4.3 Global Heart Failure Drugs Revenue Market Share by Region (2017-2028)
3 Global Heart Failure Drugs by Manufacturers
3.1 Global Top Heart Failure Drugs Manufacturers by Sales
3.1.1 Global Heart Failure Drugs Sales by Manufacturer (2017-2022)
3.1.2 Global Heart Failure Drugs Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Heart Failure Drugs Manufacturers by Revenue
3.2.1 Global Heart Failure Drugs Revenue by Manufacturer (2017-2022)
3.2.2 Global Heart Failure Drugs Revenue Share by Manufacturer (2017-2022)
3.3 Global Heart Failure Drugs Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Heart Failure Drugs Manufacturers Covered: Ranking by Revenue
3.4.2 Global Heart Failure Drugs Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Heart Failure Drugs Manufacturing Base Distribution, Product Type
3.5.1 Heart Failure Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Heart Failure Drugs Product Type
3.5.3 Date of International Manufacturers Enter into Heart Failure Drugs Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Novartis
4.1.1 Novartis Corporation Information
4.1.2 Novartis Description, Business Overview
4.1.3 Novartis Heart Failure Drugs Products Offered
4.1.4 Novartis Heart Failure Drugs Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Novartis Heart Failure Drugs Sales by Product in 2021
4.1.6 Novartis Heart Failure Drugs Sales by Application in 2021
4.1.7 Novartis Heart Failure Drugs Sales by Geographic Area in 2021
4.1.8 Novartis Recent Developments
4.2 Pfizer
4.2.1 Pfizer Corporation Information
4.2.2 Pfizer Description, Business Overview
4.2.3 Pfizer Heart Failure Drugs Products Offered
4.2.4 Pfizer Heart Failure Drugs Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Pfizer Heart Failure Drugs Sales by Product in 2021
4.2.6 Pfizer Heart Failure Drugs Sales by Application in 2021
4.2.7 Pfizer Heart Failure Drugs Sales by Geographic Area in 2021
4.2.8 Pfizer Recent Developments
4.3 AstraZeneca
4.3.1 AstraZeneca Corporation Information
4.3.2 AstraZeneca Description, Business Overview
4.3.3 AstraZeneca Heart Failure Drugs Products Offered
4.3.4 AstraZeneca Heart Failure Drugs Sales, Revenue and Gross Margin (2017-2022)
4.3.5 AstraZeneca Heart Failure Drugs Sales by Product in 2021
4.3.6 AstraZeneca Heart Failure Drugs Sales by Application in 2021
4.3.7 AstraZeneca Heart Failure Drugs Sales by Geographic Area in 2021
4.3.8 AstraZeneca Recent Developments
4.4 Hikma
4.4.1 Hikma Corporation Information
4.4.2 Hikma Description, Business Overview
4.4.3 Hikma Heart Failure Drugs Products Offered
4.4.4 Hikma Heart Failure Drugs Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Hikma Heart Failure Drugs Sales by Product in 2021
4.4.6 Hikma Heart Failure Drugs Sales by Application in 2021
4.4.7 Hikma Heart Failure Drugs Sales by Geographic Area in 2021
4.4.8 Hikma Recent Developments
4.5 Teva
4.5.1 Teva Corporation Information
4.5.2 Teva Description, Business Overview
4.5.3 Teva Heart Failure Drugs Products Offered
4.5.4 Teva Heart Failure Drugs Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Teva Heart Failure Drugs Sales by Product in 2021
4.5.6 Teva Heart Failure Drugs Sales by Application in 2021
4.5.7 Teva Heart Failure Drugs Sales by Geographic Area in 2021
4.5.8 Teva Recent Developments
4.6 Cipla
4.6.1 Cipla Corporation Information
4.6.2 Cipla Description, Business Overview
4.6.3 Cipla Heart Failure Drugs Products Offered
4.6.4 Cipla Heart Failure Drugs Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Cipla Heart Failure Drugs Sales by Product in 2021
4.6.6 Cipla Heart Failure Drugs Sales by Application in 2021
4.6.7 Cipla Heart Failure Drugs Sales by Geographic Area in 2021
4.6.8 Cipla Recent Development
4.7 Merck & Co.
4.7.1 Merck & Co. Corporation Information
4.7.2 Merck & Co. Description, Business Overview
4.7.3 Merck & Co. Heart Failure Drugs Products Offered
4.7.4 Merck & Co. Heart Failure Drugs Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Merck & Co. Heart Failure Drugs Sales by Product in 2021
4.7.6 Merck & Co. Heart Failure Drugs Sales by Application in 2021
4.7.7 Merck & Co. Heart Failure Drugs Sales by Geographic Area in 2021
4.7.8 Merck & Co. Recent Development
4.8 Amgen
4.8.1 Amgen Corporation Information
4.8.2 Amgen Description, Business Overview
4.8.3 Amgen Heart Failure Drugs Products Offered
4.8.4 Amgen Heart Failure Drugs Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Amgen Heart Failure Drugs Sales by Product in 2021
4.8.6 Amgen Heart Failure Drugs Sales by Application in 2021
4.8.7 Amgen Heart Failure Drugs Sales by Geographic Area in 2021
4.8.8 Amgen Recent Development
4.9 Roche
4.9.1 Roche Corporation Information
4.9.2 Roche Description, Business Overview
4.9.3 Roche Heart Failure Drugs Products Offered
4.9.4 Roche Heart Failure Drugs Sales, Revenue and Gross Margin (2017-2022)
4.9.5 Roche Heart Failure Drugs Sales by Product in 2021
4.9.6 Roche Heart Failure Drugs Sales by Application in 2021
4.9.7 Roche Heart Failure Drugs Sales by Geographic Area in 2021
4.9.8 Roche Recent Development
4.10 Sun Pharma
4.10.1 Sun Pharma Corporation Information
4.10.2 Sun Pharma Description, Business Overview
4.10.3 Sun Pharma Heart Failure Drugs Products Offered
4.10.4 Sun Pharma Heart Failure Drugs Sales, Revenue and Gross Margin (2017-2022)
4.10.5 Sun Pharma Heart Failure Drugs Sales by Product in 2021
4.10.6 Sun Pharma Heart Failure Drugs Sales by Application in 2021
4.10.7 Sun Pharma Heart Failure Drugs Sales by Geographic Area in 2021
4.10.8 Sun Pharma Recent Development
4.11 Mylan
4.11.1 Mylan Corporation Information
4.11.2 Mylan Description, Business Overview
4.11.3 Mylan Heart Failure Drugs Products Offered
4.11.4 Mylan Heart Failure Drugs Sales, Revenue and Gross Margin (2017-2022)
4.11.5 Mylan Heart Failure Drugs Sales by Product in 2021
4.11.6 Mylan Heart Failure Drugs Sales by Application in 2021
4.11.7 Mylan Heart Failure Drugs Sales by Geographic Area in 2021
4.11.8 Mylan Recent Development
5 Breakdown Data by Type
5.1 Global Heart Failure Drugs Sales by Type (2017-2028)
5.1.1 Global Heart Failure Drugs Sales by Type (2017-2022)
5.1.2 Global Heart Failure Drugs Sales Forecast by Type (2023-2028)
5.1.3 Global Heart Failure Drugs Sales Market Share by Type (2017-2028)
5.2 Global Heart Failure Drugs Revenue Forecast by Type (2017-2028)
5.2.1 Global Heart Failure Drugs Revenue by Type (2017-2022)
5.2.2 Global Heart Failure Drugs Revenue Forecast by Type (2023-2028)
5.2.3 Global Heart Failure Drugs Revenue Market Share by Type (2017-2028)
5.3 Heart Failure Drugs Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Heart Failure Drugs Sales by Application (2017-2028)
6.1.1 Global Heart Failure Drugs Sales by Application (2017-2022)
6.1.2 Global Heart Failure Drugs Sales Forecast by Application (2023-2028)
6.1.3 Global Heart Failure Drugs Sales Market Share by Application (2017-2028)
6.2 Global Heart Failure Drugs Revenue Forecast by Application (2017-2028)
6.2.1 Global Heart Failure Drugs Revenue by Application (2017-2022)
6.2.2 Global Heart Failure Drugs Revenue Forecast by Application (2023-2028)
6.2.3 Global Heart Failure Drugs Revenue Market Share by Application (2017-2028)
6.3 Heart Failure Drugs Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Heart Failure Drugs Market Size YoY Growth 2017-2028
7.2 North America Heart Failure Drugs Market Facts & Figures by Country
7.2.1 North America Heart Failure Drugs Sales by Country (2017-2028)
7.2.2 North America Heart Failure Drugs Revenue by Country (2017-2028)
7.3 North America Heart Failure Drugs Sales by Type
7.4 North America Heart Failure Drugs Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Heart Failure Drugs Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Heart Failure Drugs Market Facts & Figures by Region
8.2.1 Asia-Pacific Heart Failure Drugs Sales by Region (2017-2028)
8.2.2 Asia-Pacific Heart Failure Drugs Revenue by Region (2017-2028)
8.3 Asia-Pacific Heart Failure Drugs Sales by Type
8.4 Asia-Pacific Heart Failure Drugs Sales by Application
9 Europe
9.1 Europe Heart Failure Drugs Market Size YoY Growth 2017-2028
9.2 Europe Heart Failure Drugs Market Facts & Figures by Country
9.2.1 Europe Heart Failure Drugs Sales by Country (2017-2028)
9.2.2 Europe Heart Failure Drugs Revenue by Country (2017-2028)
9.3 Europe Heart Failure Drugs Sales by Type
9.4 Europe Heart Failure Drugs Sales by Application
10 Latin America
10.1 Latin America Heart Failure Drugs Market Size YoY Growth 2017-2028
10.2 Latin America Heart Failure Drugs Market Facts & Figures by Country
10.2.1 Latin America Heart Failure Drugs Sales by Country (2017-2028)
10.2.2 Latin America Heart Failure Drugs Revenue by Country (2017-2028)
10.3 Latin America Heart Failure Drugs Sales by Type
10.4 Latin America Heart Failure Drugs Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Heart Failure Drugs Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Heart Failure Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Heart Failure Drugs Sales by Country (2017-2028)
11.2.2 Middle East and Africa Heart Failure Drugs Revenue by Country (2017-2028)
11.3 Middle East and Africa Heart Failure Drugs Sales by Type
11.4 Middle East and Africa Heart Failure Drugs Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Heart Failure Drugs Supply Chain Analysis
12.2 Heart Failure Drugs Key Raw Materials and Upstream Suppliers
12.3 Heart Failure Drugs Clients Analysis
12.4 Heart Failure Drugs Sales Channel and Sales Model Analysis
12.4.1 Heart Failure Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Heart Failure Drugs Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Heart Failure Drugs Distributors
13 Market Dynamics
13.1 Heart Failure Drugs Industry Trends
13.2 Heart Failure Drugs Market Drivers
13.3 Heart Failure Drugs Market Challenges
13.4 Heart Failure Drugs Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Heart Failure Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of ACEI
Table 3. Major Manufacturers of Angiotensin II Receptor Blockers
Table 4. Major Manufacturers of ARNIs
Table 5. Major Manufacturers of Beta Blockers
Table 6. Major Manufacturers of Aldosterone Antagonists
Table 7. Major Manufacturers of Diuretics
Table 8. Global Heart Failure Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Heart Failure Drugs Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 10. Global Heart Failure Drugs Sales by Region (2017-2022) & (MT)
Table 11. Global Heart Failure Drugs Sales Forecast by Region (2023-2028) & (MT)
Table 12. Global Heart Failure Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Heart Failure Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global Heart Failure Drugs Sales by Manufacturer (2017-2022) & (MT)
Table 15. Global Heart Failure Drugs Sales Share by Manufacturer (2017-2022)
Table 16. Heart Failure Drugs Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 17. Heart Failure Drugs Revenue Share by Manufacturer (2017-2022)
Table 18. Key Manufacturers Heart Failure Drugs Price (2017-2022) & (USD/MT)
Table 19. Ranking of Global Top Heart Failure Drugs Manufacturers by Revenue (US$ Million) in 2021
Table 20. Global Heart Failure Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 21. Global Heart Failure Drugs by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Heart Failure Drugs as of 2021)
Table 22. Heart Failure Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Heart Failure Drugs Product Type
Table 24. Date of International Manufacturers Enter into Heart Failure Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Novartis Corporation Information
Table 27. Novartis Description and Business Overview
Table 28. Novartis Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 29. Novartis Heart Failure Drugs Product
Table 30. Novartis Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Product in 2021
Table 31. Novartis Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Application in 2021
Table 32. Novartis Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Geographic Area in 2021
Table 33. Novartis Recent Development
Table 34. Pfizer Corporation Information
Table 35. Pfizer Description and Business Overview
Table 36. Pfizer Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 37. Pfizer Heart Failure Drugs Product
Table 38. Pfizer Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Product in 2021
Table 39. Pfizer Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Application in 2021
Table 40. Pfizer Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Geographic Area in 2021
Table 41. Pfizer Recent Development
Table 42. AstraZeneca Corporation Information
Table 43. AstraZeneca Description and Business Overview
Table 44. AstraZeneca Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. AstraZeneca Heart Failure Drugs Product
Table 46. AstraZeneca Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Product in 2021
Table 47. AstraZeneca Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Application in 2021
Table 48. AstraZeneca Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Geographic Area in 2021
Table 49. AstraZeneca Recent Development
Table 50. Hikma Corporation Information
Table 51. Hikma Description and Business Overview
Table 52. Hikma Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 53. Hikma Heart Failure Drugs Product
Table 54. Hikma Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Product in 2021
Table 55. Hikma Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Application in 2021
Table 56. Hikma Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Geographic Area in 2021
Table 57. Hikma Recent Development
Table 58. Teva Corporation Information
Table 59. Teva Description and Business Overview
Table 60. Teva Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 61. Teva Heart Failure Drugs Product
Table 62. Teva Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Product in 2021
Table 63. Teva Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Application in 2021
Table 64. Teva Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Geographic Area in 2021
Table 65. Teva Recent Development
Table 66. Cipla Corporation Information
Table 67. Cipla Description and Business Overview
Table 68. Cipla Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 69. Cipla Heart Failure Drugs Product
Table 70. Cipla Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Product in 2021
Table 71. Cipla Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Application in 2021
Table 72. Cipla Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Geographic Area in 2021
Table 73. Merck & Co. Corporation Information
Table 74. Merck & Co. Description and Business Overview
Table 75. Merck & Co. Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 76. Merck & Co. Heart Failure Drugs Product
Table 77. Merck & Co. Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Product in 2021
Table 78. Merck & Co. Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Application in 2021
Table 79. Merck & Co. Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Geographic Area in 2021
Table 80. Amgen Corporation Information
Table 81. Amgen Description and Business Overview
Table 82. Amgen Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 83. Amgen Heart Failure Drugs Product
Table 84. Amgen Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Product in 2021
Table 85. Amgen Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Application in 2021
Table 86. Amgen Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Geographic Area in 2021
Table 87. Roche Corporation Information
Table 88. Roche Description and Business Overview
Table 89. Roche Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 90. Roche Heart Failure Drugs Product
Table 91. Roche Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Product in 2021
Table 92. Roche Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Application in 2021
Table 93. Roche Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Geographic Area in 2021
Table 94. Sun Pharma Corporation Information
Table 95. Sun Pharma Description and Business Overview
Table 96. Sun Pharma Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 97. Sun Pharma Heart Failure Drugs Product
Table 98. Sun Pharma Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Product in 2021
Table 99. Sun Pharma Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Application in 2021
Table 100. Sun Pharma Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Geographic Area in 2021
Table 101. Mylan Corporation Information
Table 102. Mylan Description and Business Overview
Table 103. Mylan Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 104. Mylan Heart Failure Drugs Product
Table 105. Mylan Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Product in 2021
Table 106. Mylan Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Application in 2021
Table 107. Mylan Heart Failure Drugs Sales Proportion of Heart Failure Drugs by Geographic Area in 2021
Table 108. Global Heart Failure Drugs Sales by Type (2017-2022) & (MT)
Table 109. Global Heart Failure Drugs Sales Forecast by Type (2023-2028) & (MT)
Table 110. Global Heart Failure Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 111. Global Heart Failure Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 112. Global Heart Failure Drugs Sales by Application (2017-2022) & (MT)
Table 113. Global Heart Failure Drugs Sales Forecast by Application (2023-2028) & (MT)
Table 114. Global Heart Failure Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 115. Global Heart Failure Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 116. North America Heart Failure Drugs Sales by Country (2017-2022) & (MT)
Table 117. North America Heart Failure Drugs Sales by Country (2023-2028) & (MT)
Table 118. North America Heart Failure Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 119. North America Heart Failure Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 120. North America Heart Failure Drugs Sales by Type (2017-2022) & (MT)
Table 121. North America Heart Failure Drugs Sales by Application (2017-2022) & (MT)
Table 122. Asia-Pacific Heart Failure Drugs Sales by Region (2017-2022) & (MT)
Table 123. Asia-Pacific Heart Failure Drugs Sales by Region (2023-2028) & (MT)
Table 124. Asia-Pacific Heart Failure Drugs Revenue by Region (2017-2028) & (US$ Million)
Table 125. Asia-Pacific Heart Failure Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 126. Asia-Pacific Heart Failure Drugs Sales by Type (2017-2022) & (MT)
Table 127. Asia-Pacific Heart Failure Drugs Sales by Application (2017-2022) & (MT)
Table 128. Europe Heart Failure Drugs Sales by Country (2017-2022) & (MT)
Table 129. Europe Heart Failure Drugs Sales by Country (2023-2028) & (MT)
Table 130. Europe Heart Failure Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 131. Europe Heart Failure Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 132. Europe Heart Failure Drugs Sales by Type (2017-2022) & (MT)
Table 133. Europe Heart Failure Drugs Sales by Application (2017-2022) & (MT)
Table 134. Latin America Heart Failure Drugs Sales by Country (2017-2022) & (MT)
Table 135. Latin America Heart Failure Drugs Sales by Country (2023-2028) & (MT)
Table 136. Latin America Heart Failure Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 137. Latin America Heart Failure Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 138. Latin America Heart Failure Drugs Sales by Type (2017-2022) & (MT)
Table 139. Latin America Heart Failure Drugs Sales by Application (2017-2022) & (MT)
Table 140. Middle East and Africa Heart Failure Drugs Sales by Country (2017-2022) & (MT)
Table 141. Middle East and Africa Heart Failure Drugs Sales by Country (2023-2028) & (MT)
Table 142. Middle East and Africa Heart Failure Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 143. Middle East and Africa Heart Failure Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 144. Middle East and Africa Heart Failure Drugs Sales by Type (2017-2022) & (MT)
Table 145. Middle East and Africa Heart Failure Drugs Sales by Application (2017-2022) & (MT)
Table 146. Heart Failure Drugs Key Raw Materials, Industry Status and Trend
Table 147. Heart Failure Drugs Key Raw Materials and Upstream Suppliers
Table 148. Heart Failure Drugs Clients Status and Trend
Table 149. Heart Failure Drugs Typical Clients
Table 150. Heart Failure Drugs Distributors
Table 151. Heart Failure Drugs Market Trends
Table 152. Heart Failure Drugs Market Drivers
Table 153. Heart Failure Drugs Market Challenges
Table 154. Heart Failure Drugs Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Heart Failure Drugs Product Picture
Figure 2. Global Heart Failure Drugs Sales Market Share by Type in 2021 & 2028
Figure 3. ACEI Product Picture
Figure 4. Angiotensin II Receptor Blockers Product Picture
Figure 5. ARNIs Product Picture
Figure 6. Beta Blockers Product Picture
Figure 7. Aldosterone Antagonists Product Picture
Figure 8. Diuretics Product Picture
Figure 9. Global Heart Failure Drugs Sales Market Share by Application in 2021 & 2028
Figure 10. Reduced Ejection Fraction Examples
Figure 11. Preserved Ejection Fraction Examples
Figure 12. Heart Failure Drugs Report Years Considered
Figure 13. Global Heart Failure Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Heart Failure Drugs Market Size 2017-2028 (US$ Million)
Figure 15. Global Heart Failure Drugs Sales 2017-2028 (MT)
Figure 16. Global Heart Failure Drugs Market Size Market Share by Region: 2022 Versus 2028
Figure 17. Global Heart Failure Drugs Sales Market Share Forecast by Region (2017-2028)
Figure 18. Global Heart Failure Drugs Revenue Market Share by Region (2017-2028)
Figure 19. Global Heart Failure Drugs Sales Share by Manufacturer in 2021
Figure 20. Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global Heart Failure Drugs Sales Market Share Forecast by Type (2017-2028)
Figure 22. Global Heart Failure Drugs Revenue Market Share Forecast by Type (2017-2028)
Figure 23. Heart Failure Drugs Average Selling Price (ASP) by Type (2017-2022) & (USD/MT)
Figure 24. Global Heart Failure Drugs Sales Market Share Forecast by Application (2017-2028)
Figure 25. Global Heart Failure Drugs Revenue Market Share Forecast by Application (2017-2028)
Figure 26. Heart Failure Drugs Average Selling Price (ASP) by Application (2017-2022) & (USD/MT)
Figure 27. North America Heart Failure Drugs Revenue 2017-2028 (US$ Million)
Figure 28. North America Heart Failure Drugs Sales Market Share by Type (2017-2022)
Figure 29. North America Heart Failure Drugs Sales Market Share by Application (2017-2022)
Figure 30. Asia-Pacific Heart Failure Drugs Revenue 2017-2028 (US$ Million)
Figure 31. Asia-Pacific Heart Failure Drugs Sales Market Share by Region (2017-2028)
Figure 32. Asia-Pacific Heart Failure Drugs Revenue Market Share by Region (2017-2028)
Figure 33. Asia-Pacific Heart Failure Drugs Sales Market Share by Type (2017-2022)
Figure 34. Asia-Pacific Heart Failure Drugs Sales Market Share by Application (2017-2022)
Figure 35. Europe Heart Failure Drugs Revenue Growth Rate 2017-2028 (US$ Million)
Figure 36. Europe Heart Failure Drugs Sales Market Share by Country (2017-2028)
Figure 37. Europe Heart Failure Drugs Revenue Market Share by Country (2017-2028)
Figure 38. Europe Heart Failure Drugs Sales Market Share by Type (2017-2022)
Figure 39. Europe Heart Failure Drugs Sales Market Share by Application (2017-2022)
Figure 40. Latin America Heart Failure Drugs Revenue Growth Rate 2017-2028 (US$ Million)
Figure 41. Latin America Heart Failure Drugs Sales Market Share by Country (2017-2028)
Figure 42. Latin America Heart Failure Drugs Revenue Market Share by Country (2017-2022)
Figure 43. Latin America Heart Failure Drugs Sales Market Share by Type (2017-2022)
Figure 44. Latin America Heart Failure Drugs Sales Market Share by Application (2017-2022)
Figure 45. Middle East and Africa Heart Failure Drugs Revenue Growth Rate 2017-2028 (US$ Million)
Figure 46. Middle East and Africa Heart Failure Drugs Sales Market Share by Country (2017-2028)
Figure 47. Middle East and Africa Heart Failure Drugs Revenue Market Share by Country (2017-2028)
Figure 48. Middle East and Africa Heart Failure Drugs Sales Market Share by Type (2017-2022)
Figure 49. Middle East and Africa Heart Failure Drugs Sales Market Share by Application (2017-2022)
Figure 50. Heart Failure Drugs Supply Chain (Upstream and Downstream Market)
Figure 51. Global Production Market Share of Heart Failure Drugs Raw Materials by Region in 2021
Figure 52. Heart Failure Drugs Distribution Channels
Figure 53. Global Heart Failure Drugs Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 54. Global Heart Failure Drugs Percentage 2017-2028: Online Sales VS Offline Sales
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Digoxin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 75

According to our LPI (LP Information) latest study, the global Digoxin market size was valued at US$ 59 million in 2023. With growing demand in downstream market, the Digoxin is forecast to a readjusted size of US$ 73 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Digoxin market. Digoxin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain op......

Global Heart Failure Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Heart Failure Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Heart Failure Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Heart Failure Drugs market. Heart Failure Drugs are expected to show stable growth in the future market. However, product differentiatio......

Global Atorvastatin Calcium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 138

According to our LPI (LP Information) latest study, the global Atorvastatin Calcium market size was valued at US$ 214.2 million in 2023. With growing demand in downstream market, the Atorvastatin Calcium is forecast to a readjusted size of US$ 362 million by 2030 with a CAGR of 7.8% during review period. The research report highlights the growth potential of the global Atorvastatin Calcium market. Atorvastatin Calcium are expected to show stable growth in the future market. However, prod......

Global Rosuvastatin Calcium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 139

According to our LPI (LP Information) latest study, the global Rosuvastatin Calcium market size was valued at US$ 514.3 million in 2023. With growing demand in downstream market, the Rosuvastatin Calcium is forecast to a readjusted size of US$ 683.6 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Rosuvastatin Calcium market. Rosuvastatin Calcium are expected to show stable growth in the future market. However, pr......

Global Atorvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 133

According to our (Global Info Research) latest study, the global Atorvastatin Calcium market size was valued at USD 225.3 million in 2023 and is forecast to a readjusted size of USD 366.1 million by 2030 with a CAGR of 7.2% during review period. Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL choleste......

Global Rosuvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 132

According to our (Global Info Research) latest study, the global Rosuvastatin Calcium market size was valued at USD 540.9 million in 2023 and is forecast to a readjusted size of USD 703.6 million by 2030 with a CAGR of 3.8% during review period. Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart att......

Cilostazol - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 118

The global Cilostazol market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cilostazol in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Cilostazol market. Injection Cilostazol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-dried P......

Rosuvastatin - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 110

Rosuvastatin medication is a statin that is used to lower bad cholesterol and prevent cardiovascular disease. It works by blocking an enzyme in the liver that makes cholesterol. It is taken by mouth and should be used together with dietary changes, exercise, and weight loss. It may also raise good cholesterol and lower triglycerides. It is sold under the brand name Crestor among others. It may be used when other statins have not worked well. The global Rosuvastatin market size is expected......

Global Congestive Heart Failure Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Congestive Heart Failure Drugs market: According to our latest research, the global Congestive Heart Failure Drugs market looks promising in the next 5 years. As of 2022, the global Congestive Heart Failure Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Congestive heart failure is a serious and complex condition in which the heart muscles are either dam......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs